By Duncan Bridgeman
Friday 23rd May 2003
|Text too small?|
The 17% lift in profit was in line with expectations, pushing Healthcare shares up another 5c to $10.75 at press time yesterday.
Chief executive Michael Daniell said the company was planning a number of
significant new product introductions, including sleeping masks, humidifier systems, breathing circuits and patient warmers.
The result included realised and unrealised foreign exchange gains of $23 million after tax.
Operating revenue for the company's core product range grew 17% in US dollar terms over the previous year.
Mr Daniell said the company expected a continuation of strong US dollar revenue growth.
Fisher & Paykel makes heated humidification products for use in respiratory care and treatment of obstructive sleep apnea (OSA), a condition that stops breathing during sleep.
No comments yet
Transpower sees no risk to credit metrics from incentive change
NZ dollar rises, an outlier amid rising Gulf tensions
Craigmore spends $32M to expand Kerikeri kiwifruit crop by 'more than a third'
CentrePort eyes further hub expansion
South Port beats guidance, earnings in line with 2018 record
Plexure sees revenue growth from White Castle deal
22nd July 2019 Morning Report
NZ dollar treading water as markets focus on Iran
MARKET CLOSE: NZ shares extend gain as passive funds bolster prices; Tourism Holdings climbs
NZ dollar headed for 1.3% weekly gain on expectations of a Fed rate cut